
Sesame seeds hold potential for ameliorating elevated blood lipid levels, particularly cholesterol, while simultaneously safeguarding the liver and other organs from harm caused by hyperlipidemia. Consequently, sesame presents itself as a promising avenue for preventing cardiovascular issues and other complications stemming from excessive blood lipids.*
Researchers hailing from Olabisi Onabanjo University in Nigeria and the University of Nebraska–Lincoln in the United States recently conducted an investigation into the effects of consuming sesame seeds on lipid profiles, liver function, and the body’s antioxidant capacity. These findings were subsequently documented and published in the journal Discover Food.
Pathologically elevated amounts of lipids circulating in the blood, a condition termed hyperlipidemia, represents a widespread public health concern that drives the development of cardiovascular diseases and contributes to over 17.9 million fatalities annually, primarily through mechanisms involving oxidative stress and organ detriment, as the research team explains.
While high blood lipid levels are generally manageable with statins, their practical medical application is constrained by associated perils such as liver toxicity and the risk of kidney failure. This underscores a persistent and critical demand for safer, naturally derived alternatives.
The investigators sought to determine if incorporating sesame seeds into the diet could address this, employing rats that had developed hyperlipidemia following a four-week regimen rich in dietary fats.
Subsequently, for the ensuing four weeks, the animals were assigned to one of four separate regimens: continuing the high-fat diet without any additional intervention, adhering to the high-fat diet supplemented with sesame seeds, following the high-fat diet alongside the statin drug atorvastatin, or consuming a standard diet enhanced with sesame seeds. Furthermore, a baseline control group consisted of animals that avoided the high-fat diet and received no treatment.
Beyond assessing impacts on total cholesterol, triglycerides, LDL cholesterol, HDL cholesterol, and HMG-CoA reductase activity, the scientists also measured markers of oxidation and indicators of tissue damage within the liver, kidneys, heart, and brain.
The researchers report that after being given the high-fat diet, the rats exhibited marked increases in total cholesterol, triglycerides, “unhealthy” LDL cholesterol, and HMG-CoA reductase activity, alongside a decrease in “healthy” HDL cholesterol levels.
The research team added that biomarkers also revealed a pronounced escalation in oxidative stress and substantial organ damage attributable to the high-fat diet (evidenced by elevated levels of AST, alkaline phosphatase, urea, and creatinine).
However, the addition of sesame seeds to the high-fat regimen proved effective in counteracting dyslipidemia; animals experienced reductions of up to 40 percent in metrics such as total cholesterol, triglycerides, and LDL cholesterol, among other improvements.
Indicators of oxidative stress also showed enhancement, and the activity of antioxidant enzymes was restored. Moreover, the research group indicated that the reduction in organ damage biomarkers surpassed the protective effects observed with atorvastatin.
In summation, the findings suggest that a diet incorporating sesame effectively alleviates hyperlipidemia and its related complications, achieving lipid-lowering outcomes comparable to those seen with atorvastatin, the researchers conclude.
Thus, sesame appears to be a promising natural therapeutic agent for managing elevated blood lipid levels, though its efficacy warrants confirmation through further clinical trials before definitive guidelines for its utilization can be established.